BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9481064)

  • 1. Capnocytophaga bacteremia: clinical features of patients and antimicrobial susceptibility of isolates.
    Lin RD; Hsueh PR; Chang SC; Luh KT
    J Formos Med Assoc; 1998 Jan; 97(1):44-8. PubMed ID: 9481064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brevundimonas vesicularis bacteremia resistant to trimethoprim-sulfamethoxazole and ceftazidime in a tertiary hospital in southern Taiwan.
    Zhang CC; Hsu HJ; Li CM
    J Microbiol Immunol Infect; 2012 Dec; 45(6):448-52. PubMed ID: 22516745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study.
    Martino R; Rámila E; Capdevila JA; Planes A; Rovira M; Ortega Md ; Plumé G; Gómez L; Sierra J
    Clin Infect Dis; 2001 Aug; 33(4):E20-2. PubMed ID: 11462207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteremia by multidrug-resistant Capnocytophaga sputigena.
    Gomez-Garces JL; Alos JI; Sanchez J; Cogollos R
    J Clin Microbiol; 1994 Apr; 32(4):1067-9. PubMed ID: 8027314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteremia due to Capnocytophaga species during chemotherapy-induced neutropenia in patients with hematological malignancies].
    Murakami K; Mori T; Kato J; Shimizu T; Kohashi S; Sakurai M; Sugita K; Hasegawa N; Murata M; Okamoto S
    Rinsho Ketsueki; 2017; 58(3):210-215. PubMed ID: 28381687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Capnocytophaga spp. bacteremia in compromised patients].
    Ramos JM; Pacho E; Bernacer M; Fernández-Roblas R; Soto C; Soriano F
    Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):206-9. PubMed ID: 8512974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capnocytophaga (Capnocytophaga ochracea group) bacteremia in hematological patients with profound granulocytopenia.
    Kristensen B; Schønheyder HC; Peterslund NA; Rosthøj S; Clausen N; Frederiksen W
    Scand J Infect Dis; 1995; 27(2):153-5. PubMed ID: 7660080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review.
    Lin JN; Lai CH; Chen YH; Lin HL; Huang CK; Chen WF; Wang JL; Chung HC; Liang SH; Lin HH
    J Microbiol Immunol Infect; 2010 Feb; 43(1):35-42. PubMed ID: 20434121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological data for patients with febrile neutropenia.
    Kanamaru A; Tatsumi Y
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains.
    Maury S; Leblanc T; Rousselot P; Legrand P; Arlet G; Cordonnier C
    Clin Infect Dis; 1999 May; 28(5):1172-4. PubMed ID: 10452663
    [No Abstract]   [Full Text] [Related]  

  • 12. Capnocytophaga bacteremia in neutropenic patients: report of two cases.
    López R; Martino R; Pericas R; Altés A; Sureda A; Brunet S
    Acta Haematol; 1994; 92(1):46-7. PubMed ID: 7985483
    [No Abstract]   [Full Text] [Related]  

  • 13. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates.
    Tsay RW; Lin LC; Chiou CS; Liao JC; Chen CH; Liu CE; Young TG
    J Microbiol Immunol Infect; 2005 Jun; 38(3):194-9. PubMed ID: 15986070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capnocytophaga sputigena bacteremia associated with acute leukemia.
    Funada H; Machi T; Yoneyama H; Matsuda T; Miura H; Ezaki T; Yokota Y
    Kansenshogaku Zasshi; 1993 Jul; 67(7):622-8. PubMed ID: 8360517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature.
    Duggan JM; Goldstein SJ; Chenoweth CE; Kauffman CA; Bradley SF
    Clin Infect Dis; 1996 Sep; 23(3):569-76. PubMed ID: 8879782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial gram-negative bacteremia in critically ill patients: epidemiologic characteristics and prognostic factors in 147 episodes.
    Jang TN; Kuo BI; Shen SH; Fung CP; Lee SH; Yang TL; Huang CS
    J Formos Med Assoc; 1999 Jul; 98(7):465-73. PubMed ID: 10462994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
    Sligl W; Taylor G; Brindley PG
    Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan.
    Hsueh PR; Teng LJ; Yang PC; Ho SW; Hsieh WC; Luh KT
    Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):568-74. PubMed ID: 9323467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
    Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.